SWOG clinical trial number
SWOG-7934
Evaluation of Acridinylamino-Methansesulfon-M-Aninsidide in Mestastatic Squamous Carcinoma of the Head and Neck
Closed
Phase
Abbreviated Title
Evaluation of Acridinylamino-Methansesulfon-M-Aninsidide in Mestastatic Squamous Carcinoma of the Head and Neck
Activated
10/05/1979
Closed
04/14/1981
Publication Information Expand/Collapse
1984
Phase II trial of Amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: A Southwest Oncology Group study.